Jamil Muhammad S, Eshun-Wilson Ingrid, Witzel T Charles, Siegfried Nandi, Figueroa Carmen, Chitembo Lastone, Msimanga-Radebe Busisiwe, Pasha Muhammad S, Hatzold Karin, Corbett Elizabeth, Barr-DiChiara Magdalena, Rodger Alison J, Weatherburn Peter, Geng Elvin, Baggaley Rachel, Johnson Cheryl
Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Washington University School of Medicine in St. Louis, St Louis, United States.
EClinicalMedicine. 2021 Jul 7;38:100991. doi: 10.1016/j.eclinm.2021.100991. eCollection 2021 Aug.
We updated a 2017 systematic review and compared the effects of HIV self-testing (HIVST) to standard HIV testing services to understand effective service delivery models among the general population.
We included randomized controlled trials (RCTs) comparing testing outcomes with HIVST to standard testing in the general population and published between January 1, 2006 and June 4, 2019. Random effects meta-analysis was conducted and pooled risk ratios (RRs) were reported. The certainty of evidence was determined using the GRADE methodology.
We identified 14 eligible RCTs, 13 of which were conducted in sub-Saharan Africa. Support provided to self-testers ranged from no/basic support to one-on-one in-person support. HIVST increased testing uptake overall (RR:2.09; 95% confidence interval: 1.69-2.58; < 0.0001;13 RCTs; moderate certainty evidence) and by service delivery model including facility-based distribution, HIVST use at facilities, secondary distribution to partners, and community-based distribution. The number of persons diagnosed HIV-positive among those tested (RR:0.81, 0.45-1.47; = 0.50; 8 RCTs; moderate certainty evidence) and number linked to HIV care/treatment among those diagnosed (RR:0.95, 0.79-1.13; = 0.52; 6 RCTs; moderate certainty evidence) were similar between HIVST and standard testing. Reported harms/adverse events with HIVST were rare and appeared similar to standard testing (RR:2.52: 0.52-12.13; = 0.25; 4 RCTs; very low certainty evidence).
HIVST appears to be safe and effective among the general population in sub-Saharan Africa with a range of delivery models. It identified and linked additional people with HIV to care. These findings support the wider availability of HIVST to reach those who may not otherwise access testing.
我们更新了一项2017年的系统评价,比较了HIV自我检测(HIVST)与标准HIV检测服务的效果,以了解普通人群中有效的服务提供模式。
我们纳入了2006年1月1日至2019年6月4日期间发表的、比较普通人群中HIVST检测结果与标准检测结果的随机对照试验(RCT)。进行随机效应荟萃分析并报告合并风险比(RR)。使用GRADE方法确定证据的确定性。
我们确定了14项符合条件的RCT,其中13项在撒哈拉以南非洲进行。向自我检测者提供的支持范围从无/基本支持到一对一的现场支持。HIVST总体上提高了检测接受率(RR:2.09;95%置信区间:1.69 - 2.58;P < 0.0001;13项RCT;中等确定性证据),并且通过包括基于设施的分发、在设施中使用HIVST、向性伴二次分发以及基于社区的分发等服务提供模式提高了检测接受率。在接受检测者中被诊断为HIV阳性的人数(RR:0.81,0.45 - 1.47;P = 0.50;8项RCT;中等确定性证据)以及在被诊断者中与HIV护理/治疗相联系的人数(RR:0.95,0.79 - 1.13;P = 0.52;6项RCT;中等确定性证据)在HIVST和标准检测之间相似。报告的与HIVST相关的危害/不良事件很少,并且似乎与标准检测相似(RR:2.52:0.52 - 12.13;P = 0.25;4项RCT;极低确定性证据)。
在撒哈拉以南非洲的普通人群中,HIVST在一系列服务提供模式下似乎是安全有效的。它识别出更多HIV感染者并使其与护理相联系。这些发现支持更广泛地提供HIVST,以覆盖那些可能无法通过其他方式获得检测的人群。